Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1

被引:333
作者
Itahana, K
Zou, Y
Itahana, Y
Martinez, JL
Beausejour, C
Jacobs, JJL
van Lohuizen, M
Band, V
Campisi, J
Dimri, GP
机构
[1] Tufts Univ New England Med Ctr, Dept Radiat Oncol, Div Radiat & Canc Biol, Boston, MA 02111 USA
[2] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
[3] Calif Pacific Med Ctr, San Francisco, CA 94115 USA
[4] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.1128/MCB.23.1.389-401.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polycomb protein Bmi-1 represses the INK4a locus, which encodes the tumor suppressors p16 and p14(ARF). Here we report that Bmi-1 is downregulated when WI-38 human fibroblasts undergo replicative senescence, but not quiescence, and extends replicative life span when overexpressed. Life span extension by Bmi-1 required the pRb, but not p53, tumor suppressor protein. Deletion analysis showed that the RING finger and helix-turn-helix domains of Bmi-1 were required for life span extension and suppression of p16. Furthermore, a RING finger deletion mutant exhibited dominant negative activity, inducing p16 and premature senescence. Interestingly, presenescent cultures of some, but not all, human fibroblasts contained growth-arrested cells expressing high levels of p16 and apparently arrested by a p53- and telomere-independent mechanism. Bmi-1 selectively extended the life span of these cultures. Low O-2 concentrations had no effect on p16 levels or life span extension by Bmi-1 but reduced expression of the p53 target, p21. We propose that some human fibroblast strains are more sensitive to stress-induced senescence and have both p16-dependent and p53/telomere-dependent pathways of senescence. Our data suggest that Bmi-1 extends the replicative life span of human fibroblasts by suppressing the p16-dependent senescence pathway.
引用
收藏
页码:389 / 401
页数:13
相关论文
共 66 条
[1]   Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts [J].
Alcorta, DA ;
Xiong, Y ;
Phelps, D ;
Hannon, G ;
Beach, D ;
Barrett, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13742-13747
[2]   Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian Polycomb complex [J].
Alkema, MJ ;
Bronk, M ;
Verhoeven, E ;
Otte, A ;
vantVeer, LT ;
Berns, A ;
vanLohuizen, M .
GENES & DEVELOPMENT, 1997, 11 (02) :226-240
[3]   INCREASED ACTIVITY OF P53 IN SENESCING FIBROBLASTS [J].
ATADJA, P ;
WONG, H ;
GARKAVTSEV, I ;
VEILLETTE, C ;
RIABOWOL, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8348-8352
[4]  
BALIN AK, 1984, J EXP MED, V160, P152, DOI 10.1084/jem.160.1.152
[5]  
BOND JA, 1994, ONCOGENE, V9, P1885
[6]  
Bond JA, 1999, MOL CELL BIOL, V19, P3103
[7]   Cellular senescence as a tumor-suppressor mechanism [J].
Campisi, J .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S27-S31
[8]   Replicative senescence: An old lives' tale? [J].
Campisi, J .
CELL, 1996, 84 (04) :497-500
[9]  
Chen QM, 2000, ANN NY ACAD SCI, V908, P111
[10]   p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis [J].
Chin, L ;
Artandi, SE ;
Shen, Q ;
Tam, A ;
Lee, SL ;
Gottlieb, GJ ;
Greider, CW ;
DePinho, RA .
CELL, 1999, 97 (04) :527-538